Sequana Medical said the first implantation of the alfapump in the U.S. at Mount Sinai Hospital received FDA approval for the treatment of recurrent or refractory ascites due to liver cirrhosis.

Ghent, Belgium, 26 February 2026 - Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), a pioneer in the treatment of drug-resistant fluid overload in liver disease, ...

As scar tissue replaces healthy liver tissue, the liver can no longer function properly. Ascites is the accumulation of fluid in the abdominal cavity, causing swelling and discomfort. It’s a common ...

Sequana Medical said the company now has five medical centers using its alfapump, the first FDA-approved active implantable medical device to treat liver ascites due to cirrhosis. The new ...

Evaluation of the appropriateness of a potential candidate for OLT is a complex process and involves a multidisciplinary approach. The evaluation begins with a thorough patient history and physical ...

Mumbai: In a rare and highly complex procedure, doctors at Gleneagles Hospital Parel performed a split liver transplant from ...

Mumbai: A 38-year-old deceased Dombivli man's liver saved two lives in the city: one of a 44-year-old man and another of a three-year-old child. Both suffered from severe liver disease.The donation ...

A pyogenic liver abscess is a pus-filled sac in the liver that occurs due to infection or injury. Treatment involves antibiotics to address the infection. Drainage may also be necessary to help ...